Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine
出版年份 2019 全文链接
标题
Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume 67, Issue 2, Pages -
出版商
Wiley
发表日期
2019-11-14
DOI
10.1002/pbc.28081
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma free metanephrines for diagnosis of neuroblastoma patients
- (2019) Sebastiano Barco et al. CLINICAL BIOCHEMISTRY
- Opportunities and challenges of circulating biomarkers in neuroblastoma
- (2019) Ricky M. Trigg et al. Open Biology
- Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy
- (2019) Mirko Peitzsch et al. CLINICA CHIMICA ACTA
- 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients
- (2018) I.R.N. Verly et al. EUROPEAN JOURNAL OF CANCER
- Updates in Diagnosis, Management, and Treatment of Neuroblastoma
- (2018) Caroline C. Swift et al. RADIOGRAPHICS
- Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or DeconjugatedO-Methylated Catecholamine Metabolites
- (2018) Graeme Eisenhofer et al. CLINICAL CHEMISTRY
- Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients
- (2017) Iedan R.N. Verly et al. EUROPEAN JOURNAL OF CANCER
- Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
- (2017) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma
- (2017) Marco Lodrini et al. Oncotarget
- Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers
- (2017) Leo Lam et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: Relevance to the diagnosis of neuroblastoma
- (2015) Laura Crosazzo Franscini et al. PEDIATRIC BLOOD & CANCER
- Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: Report from the Italian Cooperative Group for Neuroblastoma
- (2014) Sebastiano Barco et al. CLINICAL BIOCHEMISTRY
- Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
- (2014) Jacques W. M. Lenders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring
- (2011) Rachel A. Egler et al. Proteomics Clinical Applications
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice
- (2010) S J Smith et al. EYE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Reference intervals for urinary catecholamines and metabolites from birth to adulthood
- (2008) Eric Pussard et al. CLINICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search